Application Information

This drug has been submitted to the FDA under the reference 022386/001.

Names and composition

"PRANDIMET" is the commercial name of a drug composed of METFORMIN HYDROCHLORIDE and REPAGLINIDE.

Forms

ApplId/ProductId Drug name Active ingredient Form Strenght
022386/001 PRANDIMET METFORMIN HYDROCHLORIDE; REPAGLINIDE TABLET/ORAL 500MG and 1MG
022386/002 PRANDIMET METFORMIN HYDROCHLORIDE; REPAGLINIDE TABLET/ORAL 500MG and 2MG

Similar Active Ingredient

ApplId/ProductId Drug name Active ingredient Form Strenght
022386/001 PRANDIMET METFORMIN HYDROCHLORIDE; REPAGLINIDE TABLET/ORAL 500MG and 1MG
022386/002 PRANDIMET METFORMIN HYDROCHLORIDE; REPAGLINIDE TABLET/ORAL 500MG and 2MG
200624/001 REPAGLINIDE AND METFORMIN HYDROCHLORIDE METFORMIN HYDROCHLORIDE; REPAGLINIDE TABLET/ORAL 500MG and 1MG
200624/002 REPAGLINIDE AND METFORMIN HYDROCHLORIDE METFORMIN HYDROCHLORIDE; REPAGLINIDE TABLET/ORAL 500MG and 2MG

Ask a doctor

A licensed doctor will try to answer your question for free as quickly as possible. Free of charge during the beta period.

Related

Browse by letter
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

© Medications.li 2015-2017 - All rights reserved